BC subtypes are diagnosed by the presence or absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), and tumors that lack all three receptors are triple-negative BC (TNBC) [2]. This evidence concerns the gene PGR and breast cancer.